We are live on ! Find out more
PRTK

Paratek Pharmaceuticals, Inc.
PRTK

Delisted

PRTK was delisted on the 20th of September, 2023.

Back to rankings

100 hedge funds and large institutions have $121M invested in Paratek Pharmaceuticals, Inc. in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 29 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

454% more call options, than puts

Call options by funds: $2.21M | Put options by funds: $399K

14% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 29

13% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 15

9% more capital invested

Capital invested by funds: $111M → $121M (+$10.2M)

1% more funds holding

Funds holding: 99 → 100 (+1)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
100
Holders Change
+1
Holders Change %
+1.01%
% of All Funds
2.02%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
17
Increased
33
Reduced
29
Closed
15
Calls
$2.21M
Puts
$399K
Net Calls
+$1.81M
Net Calls Change
+$1.04M

Top Buyers

Rank Fund Capital Flow
1
BC
Bruce & Co
Illinois
+$1.55M
2
BlackRock
BlackRock
New York
+$1.33M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.26M
4
WVP
Worth Venture Partners
New Jersey
+$854K
5
GAI
General American Investors
New York
+$718K

Top Sellers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$2M
2
Morgan Stanley
Morgan Stanley
New York
-$685K
3
BBVA
Banco Bilbao Vizcaya Argentaria
Spain
-$548K
4
Squarepoint
Squarepoint
New York
-$471K
5
WIC
Water Island Capital
New York
-$449K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
51
Tower Research Capital (TRC)
New York
$243K +$187K +37,786 +534%
Financial Engines Advisors
52
Financial Engines Advisors
California
$216K +$198K +40,000 New
Squarepoint
53
Squarepoint
New York
$169K -$471K -95,162 -75%
AQR Capital Management
54
AQR Capital Management
Connecticut
$168K +$92.7K +18,719 +152%
VF
55
Virtu Financial
New York
$156K +$143K +28,877 New
Manulife (Manufacturers Life Insurance)
56
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$142K – – –
AIG
57
American International Group
New York
$141K +$5.64K +1,140 +5%
EMG
58
ETF Managers Group
New Jersey
$140K +$63.7K +12,864 +102%
KM
59
Kalos Management
Georgia
$136K -$2.48K -500 -2%
SFI
60
Susquehanna Fundamental Investments
Pennsylvania
$127K +$116K +23,500 New
MIM
61
MetLife Investment Management
New Jersey
$115K -$1.34K -270 -1%
TA
62
Teton Advisors
New York
$103K -$19.8K -4,000 -17%
JP Morgan Chase
63
JP Morgan Chase
New York
$89K +$12.6K +2,543 +19%
SC
64
Scholtz & Company
Connecticut
$88K -$36.1K -7,300 -31%
HighTower Advisors
65
HighTower Advisors
Illinois
$84K – – –
MLICM
66
Metropolitan Life Insurance Company (MetLife)
New York
$78.7K -$1.35K -272 -2%
VOYA Investment Management
67
VOYA Investment Management
Georgia
$78K – – –
GI
68
GAMCO Investors
Connecticut
$77K -$173K -35,000 -71%
RJFSA
69
Raymond James Financial Services Advisors
Florida
$77K +$70.3K +14,202 New
HAG
70
HighPoint Advisor Group
Illinois
$76K – – –
GF
71
Gabelli Funds
New York
$63K – – –
State Board of Administration of Florida Retirement System
72
State Board of Administration of Florida Retirement System
Florida
$58K – – –
CCB
73
Cutter & Co Brokerage
Missouri
$57K -$8.29K -1,675 -14%
Walleye Capital
74
Walleye Capital
New York
$57K +$52.5K +10,600 New
ZIM
75
Zacks Investment Management
Illinois
$55K +$50.4K +10,180 New
1 2
3
4 5

PRTK Hedge Fund Activity: Q3 2020 in Review

100 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Paratek Pharmaceuticals, Inc. (PRTK) for Q3 2020, worth a combined $121M — up 9.2% from $111M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new PRTK positions and 15 closed out — a net gain of 2 holders — while 33 added to existing stakes and 29 trimmed.

The largest buyer was Bruce & Co, adding an estimated $1.55M. The largest seller was D.E. Shaw & Co, cutting an estimated $2M.

  • 100 institutional investors held Paratek Pharmaceuticals, Inc. (PRTK) as of Q3 2020, up from 99 in Q2 2020.
  • Funds reported $121M of Paratek Pharmaceuticals, Inc. stock for Q3 2020, up 9.2% quarter-over-quarter.
  • 17 funds opened new Paratek Pharmaceuticals, Inc. positions in Q3 2020 and 15 closed out, a net change of +2 holders.
  • The largest Paratek Pharmaceuticals, Inc. buyer in Q3 2020 was Bruce & Co, an estimated $1.55M added.
  • The largest Paratek Pharmaceuticals, Inc. seller in Q3 2020 was D.E. Shaw & Co, an estimated $2M sold.

Based on aggregated 13F filings for Q3 2020.